WuXi AppTec: Net Profit Boosted by Partial Sale of WuXi XDC Cayman Stake >603259.SH

Dow JonesApr 28 05:31 ET

Guotou Securities: The investment and financing environment for Innovative Drugs is rebounding, CXO Orders and performance improvements are expected.

Global investment and financing in Innovative Drugs continues to improve, and a recovery in R&D demand is anticipated; new Orders are recovering in a timely manner, and there is optimism for improved CXO performance in 2025.

Zhitong FinanceApr 28 04:34 ET

We Think WuXi XDC Cayman (HKG:2268) Can Stay On Top Of Its Debt

Simply Wall StApr 23 02:02 ET

Trending Industry Today: SKB BIO-B Leads Losses In Biotechnology Stocks

Moomoo NewsApr 16 02:20 ET

Hong Kong stocks close | Under the shadow of tariffs, major indices performed unevenly. ZHOU HEI YA surged nearly 8%, leading the Consumer stocks to break through.

① How did Trump's tariff policy lead to a divergence in the Hong Kong stock market? ② Why does HTSC still recommend allocating to Hong Kong stock dividend direction despite tariff disruptions?

cls.cnApr 15 04:44 ET

WUXI XDC (02268.HK) granted 5.39 million restricted shares.

Glory Share on April 14 announced that WUXI XDC (02268.HK), on April 14, 2025, in accordance with the 2024 share plan, approved the grant of 5.39 million restricted shares to 287 grantees (of which three are Directors and the remaining 284 grantees are group employees).

Gelonghui FinanceApr 14 08:57 ET